Search results
Dilip Shanghvi (born 1 October 1955) is an Indian billionaire businessman. As the founder of Sun Pharmaceuticals, he is one of the country's richest people. The Government of India awarded him the civilian honor of the Padma Shri in 2016. India Today magazine ranked him 8th in India's most powerful people of 2017 list.
6 days ago · The son of a pharmaceuticals distributor, Dilip Shanghvi borrowed $200 from his father to start Sun Pharmaceutical Industries in 1983 to make psychiatric...
Dilip Shanghvi is the Founder and Chairman and Managing Director of Sun Pharmaceutical Industries Limited. He is also the Chairman of Sun Pharma Advanced Research Company Ltd., which is engaged in R&D of new innovative drugs and delivery technologies.
Oct 11, 2023 · Son of a pharma distributor, Dilip Shanghvi borrowed $200 from his father to start Sun Pharmaceutical Industries in 1983 to make psychiatric drugs. The company...
Dilip Shanghvi is the founder of Sun Pharmaceuticals has extensive industrial experience in the pharmaceutical industry. A first-generation entrepreneur, Mr. Shanghvi has won numerous awards and recognitions, including Forbes’s Entrepreneur of the Year Award (2014), Economic Times’ Business Leader of the Year (2014), CNN IBN’s Indian of ...
Jul 11, 2023 · Under Dilip Shanghvi, Sun Pharmaceutical Industries Limited, India’s largest pharma company, is building additional engines of growth with an eye on the future, especially the specialty...
4 days ago · Overview. Shanghvi is the founder of Sun Pharmaceutical Industries, a generic drugmaker with revenue of $5.4 billion in the year to March 31, 2023. The Mumbai-based company has more than 40...
5 days ago · Dilip Shanghvi, managing director, Sun Pharma; Image: Vikas Khot. S un Pharmaceuticals recently announced results from a Phase 1 multiple ascending-dose study evaluating the safety, tolerability ...
5 days ago · In the 2023-24 annual report, Chairman and Managing Director Dilip Shanghvi said: “Sun Pharma had a strong net cash position of approximately $2.4 billion, which enables us to explore inorganic opportunities, including but not limited to strengthening our global specialty portfolio.”
Dilip Shanghvi, Indian business executive who was the founder (1983) of Sun Pharmaceutical Industries Ltd., which became the largest pharmaceutical company in India and one of the largest generic-drug producers in the world. Learn more about Shanghvi’s life and career.
